Clinical trial
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
NCT02095379 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oligosecretary Myeloma: Prevalence and Its Clinical Significance
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- February 28, 2014
- Enrollment
- 390 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.